Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $60M

Overview

Founded in 1979 and headquartered in Chelmsford, Massachusetts, ZOLL Medical is a leading provider of medical devices and software solutions focused on critical care and resuscitation. The company operates across key sectors including Public Safety, EMS & Fire, Hospitals, and Cardiac Patient Management, offering products like defibrillators, automated CPR systems, wearable defibrillators (LifeVest), and data management software. As a subsidiary of Asahi Kasei, ZOLL is a mature, revenue-generating commercial entity with a strong global presence, leveraging innovation to address life-threatening cardiovascular and respiratory emergencies.

CardiovascularSleep ApneaCritical Care

Technology Platform

Integrated hardware-software platforms for resuscitation, cardiac monitoring, and sleep apnea management, featuring defibrillators, automated CPR, wearable cardiac monitors, and implantable neurostimulation.

Funding History

2
Total raised:$60M
Series B$40M
Series A$20M

Opportunities

Expansion into the large and growing sleep apnea market via the WatchPAT diagnostic and remedē implantable therapy offers a significant new growth vector.
The increasing global emphasis on public access defibrillation and improving out-of-hospital cardiac arrest survival rates drives demand for its core resuscitation products and data systems.

Risk Factors

Faces intense competition from large, well-capitalized players like Philips and Stryker across core product lines.
Regulatory changes and reimbursement pressures, particularly for higher-cost devices like the LifeVest and remedē implant, could significantly impact profitability and market access.

Competitive Landscape

ZOLL competes in fragmented but competitive segments. In defibrillators/AEDs and emergency care, key rivals are Philips and Stryker (Physio-Control). In wearable defibrillators, it is the market leader. In sleep apnea, it competes with giants ResMed and Philips in diagnostics/therapy, while its remedē System holds a unique niche in central sleep apnea.